Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-19-006857

President & CEO acquired 5,729 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

USMAN NASSIM · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-01-31 Exercise or conversion : show line 1 in the form +5,729 $4.63 $26,525 11,041 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-01-31 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −5,729 $4.63 2027-07-11 5,729 269,271 D
Loading xslF345X03/doc4.xml…